Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 21 - 30 of 200 for wx. (0.07 seconds)

WuXi PharmaTech will pay $151 million to acquire...
Sundia MediTech Company, a Shanghai-based CRO, has...
There were two items of broad significance and a host of...
NovaMed Pharmaceuticals Inc., a CRO and out-sourced...
WuXi PharmaTech held a conference yesterday with its...
KPMG released a 2008 venture capital forecast, drawn from...
The China CRO industry received coverage last...
Charles River Labs said its China CRO work comes...
According to China Central TV, Novartis produced 2.5...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here